secwatch.observer — SEC 8-K summary
======================================

Issuer:     DIVERSIFIED HEALTHCARE TRUST (DHC)
CIK:        0001075415
Form:       8-K
Filed at:   2022-03-30T23:59:59+00:00
Accession:  0001104659-22-039564
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Diversified Healthcare Trust elects David A. Pierce as independent trustee, board expands to seven
--------------------------------------------------------------------------------

- Board increased to seven trustees; David A. Pierce elected as independent trustee effective March 29, 2022.
- Pierce is EVP and President, MedSurg at Boston Scientific; also serves on boards of MDMA and MassMedic.
- His term expires at the 2023 annual meeting; receives standard independent trustee compensation.
- Company entered into standard indemnification agreement with Pierce on same terms as other trustees.
- No arrangements or transactions requiring disclosure under Item 404(a) were identified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1075415/000110465922039564/0001104659-22-039564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1075415/000110465922039564/tm2210623d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-039564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer